Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M573Revenue $M3.4Net Margin (%)-2,628.2Z-Score0
Enterprise Value $M435EPS $-1.3Operating Margin %-2,632.4F-Score1
P/E(ttm))0Cash Flow Per Share $-0.5Pre-tax Margin (%)-2,628.2Higher ROA y-yN
Price/Book7.410-y EBITDA Growth Rate %0Quick Ratio19.3Cash flow > EarningsY
Price/Sales1515-y EBITDA Growth Rate %-23.1Current Ratio5.2Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-64.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-119.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M92.6ROI % (ttm)-78.3Gross Margin Increase y-yN

Gurus Latest Trades with OREX

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 80. The trades of Premium Gurus are not included unless they are in your Personalized List

TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OREXJohn Burbank 2012-09-30 Buy 0.2%$3.77 - $7.39
($5.32)
$ 6.0414%New holding, 750000 sh.750,000
OREXGeorge Soros 2012-06-30 Sold Out -0.03%$3.16 - $6.37
($3.76)
$ 6.0461%Sold Out0
OREXGeorge Soros 2012-03-31 Buy 0.03%$1.68 - $5.01
($3.11)
$ 6.0494%New holding, 500000 sh.500,000
OREXJean-Marie Eveillard 2010-09-30 Sold Out -0.01%$3.9 - $6.77
($4.98)
$ 6.0421%Sold Out0
OREXJean-Marie Eveillard 2010-06-30 Add$4.05 - $7.04
($5.57)
$ 6.048%Add 74.07%470,000
OREXJean-Marie Eveillard 2010-03-31 Add$5.9 - $7.66
($6.55)
$ 6.04-8%Add 22.73%270,000
OREXJean-Marie Eveillard 2009-12-31 Add0.01%$6.44 - $9.39
($7.57)
$ 6.04-20%Add 83.33%220,000
OREXJean-Marie Eveillard 2009-09-30 Buy 0.01%$5.2 - $10.34
($7.89)
$ 6.04-23%New holding, 120000 sh.120,000
OREXBill Gates 2009-06-30 Sold Out $1.89 - $5.21
($3.19)
$ 6.0489%Sold Out0
OREXJean-Marie Eveillard 2007-09-30 Sold Out $13.21 - $15.88
($14.5)
$ 6.04-58%Sold Out0
OREXJean-Marie Eveillard 2007-06-30 Buy $13.75 - $17.94
($16)
$ 6.04-62%New holding, 21400 sh.21,400
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OREX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
OREX John Burbank 2013-03-31750,0000.810.19
Premium Most recent portfolio changes are included for Premium Members only!


OREX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Booth Mark DChief Commercial Officer 2013-03-11Sell27,685$6.67-9.45view
Booth Mark DChief Commercial Officer 2013-01-15Sell22,315$6.67-9.45view
NARACHI MICHAELPresident and CEO 2012-07-17Sell150,000$7.66-21.15view
Turner Heather DSVP, Gen. Counsel & Secretary 2012-07-17Sell82,433$7.68-21.35view
Hagan Joseph PChief Business Officer 2012-07-13Sell30,000$6.77-10.78view
NARACHI MICHAELPresident and CEO 2012-07-13Sell150,000$6.7-9.85view
Hagan Joseph PChief Business Officer 2012-06-29Sell108,000$5.539.22view
NARACHI MICHAELPresident and CEO 2012-06-29Sell225,000$5.892.55view
Booth Mark DChief Commercial Officer 2012-06-28Sell103,309$5.666.71view
DOMAIN PARTERS VII L P10% Owner 2011-12-22Buy461,265$1.45316.55view

Press Releases about OREX:

Quarterly/Annual Reports about OREX:

News about OREX:

Articles On GuruFocus.com
Weekly CEO Sells Highlight: Orexigen Therapeutics Inc, Gas Natural Inc, The Middleby Corporation, an Jul 15 2012 
Weekly CEO Sells Highlight: Gas Natural Inc, Encore Bancshares Inc, Staples Inc, and Orexigen Therap Jul 08 2012 
Arena Facing Increased Pressure from Peers Apr 23 2012 
Arena Could Dip If Lorcaserin Fails Again Apr 22 2012 
Vivus Could Rocket on Success of Qnexa Apr 13 2012 
Steve Cohen Buys ACOR, DPZ, GXDX, NDN, and OREX Feb 07 2011 
Steve Cohen Bets On Orexigen Ahead of FDA Approval Jan 31 2011 
Orexigen Therapeutics Inc. Reports Operating Results (10-Q) Nov 04 2010 
Orexigen Therapeutics Inc. Reports Operating Results (10-Q) Aug 06 2010 
Orexigen Therapeutics Inc. (OREX) CFO and Treasurer Graham K Cooper sells 82,500 Shares Dec 23 2009 

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial